NAT1 and neoplasm: Moreover, its expression was significantly correlated with tumor grading and inversely correlated with the expression of its putative targets, N-acetyltransferase-1 (NAT1) and forkhead box A1 (FOXA1), the presence of which is specific for better outcomes for patients with luminal tumors [236].